Quantcast
Last updated on April 24, 2014 at 5:50 EDT

Latest chemotherapy Stories

2013-07-11 16:05:38

Indication of considerable added benefit for overall survival / indications of greater harm from side effects The drug aflibercept (trade name: Zaltrap) has been approved in Germany since February 2013 in combination with a certain chemotherapy for adults with metastatic colorectal cancer in whom chemotherapy with oxaliplatin could not stop the disease from progressing. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG) the German...

2013-07-10 08:26:32

May enable treatment of patients previously deemed untreatable WESTMINSTER, Colo., July 10, 2013 /PRNewswire/ -- Case reports published in the Journal of Cardiovascular and Interventional Radiology found that by using the Surefire Infusion System, radioembolization could be successfully performed without the need to protect nearby blood vessels, a significant advance that may enable doctors to safely extend liver cancer treatment to patients who were previously deemed untreatable....

2013-07-09 21:24:33

New evidence suggests that using advanced genetics technologies to monitor for remaining cancer cells after treatment may soon become an effective tool to inform treatment decisions and ultimately predict patient outcomes for patients with a particularly aggressive form of acute lymphocytic leukemia (ALL). Study results were published online today in Blood, the Journal of the American Society of Hematology (ASH). Approximately 25 to 30 percent of all adults with ALL, the second most common...

2013-07-09 12:27:34

WASHINGTON, July 9, 2013 /PRNewswire-USNewswire/ -- New evidence suggests that using advanced genetics technologies to monitor for remaining cancer cells after treatment may soon become an effective tool to inform treatment decisions and ultimately predict patient outcomes for patients with a particularly aggressive form of acute lymphocytic leukemia (ALL). Study results were published online today in Blood, the Journal of the American Society of Hematology (ASH). Approximately 25...

2013-07-09 08:27:54

Dr. Michael Har-Noy, founder and CEO of Immunovative Therapies, a biotech company in Israel, discusses a unique approach to cancer treatment, in which its cellular-based drugs stimulate the host immune system to target and kill malignant cells. NEW YORK, July 9, 2013 /PRNewswire-iReach/ -- The most promising way to develop curative treatment that eliminates every cancer cell in a patient, says Dr. Michael Har-Noy, founder and CEO of Immunovative Therapies Ltd., would be by...

2013-07-02 23:27:26

Easier access to ultrasound services may enable earlier cancer diagnosis for treatment Austin, TX (PRWEB) July 02, 2013 Oncura Partners Holdings, Inc. is proud to announce the launch of Oncura Partners Diagnostics, LLC (OP Diagnostics), which will provide remote ultrasound services to veterinarians . OP Diagnostics recently signed an exclusive distribution agreement for the SonixTablet, which is the only ultrasound product available today with real-time telemedicine. The SonixTablet is...

2013-07-02 23:05:06

San Manuel Band of Mission Indians Oncology Center and Biospecimen Laboratory allows for research, customized treatment and follow-up to patient’s specific cancer. Loma Linda, CA. (PRWEB) July 02, 2013 When Diana Bibo’s battle with cancer began in 2000, she underwent chemotherapy treatment in an open room with six infusion chairs and three nurses. Now, thirteen years later, the Redlands resident visits the beautifully designed Loma Linda University Cancer Center (LLUCC) three times a...

2013-07-02 08:26:58

Trial Adds Immunotherapy to Current Standard of Care Regimen SEATTLE, July 2, 2013 /PRNewswire/ -- VentiRx Pharmaceuticals, Inc. announced today the initiation of the ACTIVE8 clinical trial, a randomized, placebo-controlled, Phase 2 trial evaluating VTX-2337 in combination with a standard of care regimen, cetuximab, platinum and 5 Fluorouracil (5-FU), in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. (Logo:...

2013-07-01 20:21:10

Cancer Treatment Centers of America at Eastern Regional Medical Center Expands its Stem Cell Transplant & Cell Therapy Program, Draws Patients from Across the Northeast PHILADELPHIA, July 1, 2013 /PRNewswire/ -- Cancer Treatment Centers of America (CTCA) at Eastern Regional Medical Center proudly opened its new stem cell transplant center to patients with hematologic malignancies today. The 17,000 square foot center includes eight state-of-the-art inpatient rooms, along with a...

2013-06-27 23:02:33

Got your Back Pax and My Chemo Cocktail & Me, a powerful combination that combines a women’s chemo support pax and a practical chemo guide for beginners. Developed and launched by two breast cancer survivors. Waycross, GA (PRWEB) June 27, 2013 Today Care Pax & Co. launched their first two products – Got your Back Pax and My Chemo Cocktail & Me – Bringing Order, Peace and Joy to a Twisted Adventure. The products were created by cancer survivors in an effort to address the...


Latest chemotherapy Reference Libraries

Intravenous Therapy
2013-04-30 13:16:16

Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...

Antiviral Chemistry & Chemotherapy
2012-04-25 09:59:26

Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...

More Articles (2 articles) »